大型医院系统放宽MRI对比剂政策后肾功能不全患者增强MRI可及性与NSF监测
回顾性分析2023年7月至2025年6月大型医院系统207091份增强MRI医嘱,其中2911份(1.4%)来自急性肾损伤或透析患者,1440份完成、1459份取消。随访中位1.09年未发现肾源性系统性纤维化病例。
要点
- 急性肾损伤或透析患者的增强MRI医嘱完成率为49.5%,半数因故取消。
- 放宽对比剂政策后随访期内未诊断出肾源性系统性纤维化。
- 住院来源与该类患者医嘱取消关系密切,需关注住院流程中的预约完成情况。
核心结论
- 放宽对比剂政策允许急性或慢性肾功能衰竭患者使用钆对比剂后,未出现任何肾源性系统性纤维化诊断。
- 急性肾损伤或透析状态虽与较高取消率相关,但多因素校正后关联明显减弱。
研究设计与样本
- 回顾性研究纳入2023年7月1日至2025年6月30日本医疗系统内所有开具增强MRI医嘱的患者,共207091份医嘱。
- 急性肾损伤或透析患者医嘱2911份,其中1440份完成、1459份取消。
- 通过ICD-10编码检索问题列表和就诊诊断以识别可能的肾源性系统性纤维化病例。
- 随访中位时间为1.09年(IQR:0.56,1.57)。
关键影像表现/征象
- 91.3%的急性肾损伤或透析患者增强MRI医嘱来自住院场景,95.4%来自学术型院区。
- 该类患者医嘱取消中住院来源占比高,是单因素与多因素分析结果差异的主要来源。
诊断标准与关键数值
- 急性肾损伤或透析患者对比非此类患者的增强MRI医嘱取消率单因素OR为8.0(95%CI:7.4,8.6)。
- 多因素校正后急性肾损伤或透析状态与取消的关联为校正OR 1.3(95%CI:1.2,1.4)。
临床应用与阅片要点
- 对急性肾损伤或透析患者的增强MRI医嘱,放射科可重点核查住院订单的临床必要性与预约可行性。
- 肾功能不全患者使用钆对比剂的完成路径中,住院流程的取消风险是需要关注的实际环节。
局限性
- 该研究为回顾性研究,来源为单一医院系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate access to contrast-enhanced MRI among patients with acute or chronic renal failure after implementation of a more permissive contrast policy and determine whether any patients developed nephrogenic systemic fibrosis (NSF).
MATERIALS AND METHODS: This retrospective study included all patients who had an order for contrast-enhanced MRI in our healthcare system between July 1st, 2023 and June 30th, 2025. Each exam was categorized as completed or cancelled, and multivariable analysis was performed to identify factors associated with exam cancellation. Potential diagnoses of NSF were identified by searching the problem list and encounter diagnoses using ICD-10 codes.
RESULTS: Of 207,091 orders placed for contrast-enhanced MRI, 2911 (1.4%) were placed in patients with AKI/dialysis. Of these, 1440 (49.5%) were completed and 1459 (50.1%) were canceled. Over the two-year study period, with a median of 1.09 years (IQR: 0.56, 1.57) of clinical follow-up, there were no cases of NSF. Most orders in patients with AKI/dialysis occurred in the inpatient setting (91.3%, N=2658) and at an academic facility (95.4%, N=2798). Although AKI/dialysis was significantly associated with a higher cancellation rate (OR of 8.0; 95% CI: 7.4, 8.6), the effect was much less pronounced in multivariable analysis (adjusted OR of 1.3; 95% CI: 1.2, 1.4), attributable to the high frequency of inpatient orders among patients with AKI/dialysis and high rate of canceled exams among inpatients.
CONCLUSION: Implementation of a more permissive contrast policy allowing for administration of GBCA in patients with acute or chronic renal failure did not result in any diagnoses of NSF.
引用
- Ludwig, Zhang, Minor, et al. Implementation of a New MRI Contrast Policy at a Large Hospital System: Access to Contrast-Enhanced MRI and Development of NSF in Patients with Renal Insufficiency. Acad Radiol. 2026. PMID: 42309956. doi:10.1016/j.acra.2026.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。